Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemo-free Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05114720
What this trial is testing

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 559
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Testing effectiveness (Phase 2)UnknownNCT02409849
What this trial is testing

Octreotide LAR as Maintenance Treatment for Patients With NEC

Who this might be right for
Gastro-entero-pancreatic CarcinomaEsophageal Neuroendocrine Carcinoma
Peking University 92
Not applicableLooking for participantsNCT06719232
What this trial is testing

Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation

Who this might be right for
Interstitial CystitisRecurrent CystitisHaemorrhagic Cystitis+5 more
Jahn Ferenc South Pest Teaching Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT05475678
What this trial is testing

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast CancerCamrelizumab
Zhenzhen Liu 369
Testing effectiveness (Phase 2)Looking for participantsNCT06970912
What this trial is testing

CtDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHigh-risk Breast CancerEarly-Stage Breast Cancer+3 more
Peking University People's Hospital 393
Large-scale testing (Phase 3)Study completedNCT00027859
What this trial is testing

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT00929214
What this trial is testing

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 35
Not applicableUnknownNCT02471027
What this trial is testing

The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Yu mei Wu 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00642603
What this trial is testing

Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231250
What this trial is testing

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaChemo-free TherapyBispecific Antibody
Li Zhiming 40
Not applicableLooking for participantsNCT06120374
What this trial is testing

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

Who this might be right for
Urothelial Carcinoma
Peking University First Hospital 178
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Not applicableStudy completedNCT05366725
What this trial is testing

Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

Who this might be right for
Urothelial Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 106
Large-scale testing (Phase 3)UnknownNCT03423849
What this trial is testing

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

Who this might be right for
Breast CancerChemotherapy EffectDisease-free Survival
Zhiyong Yu 200
Large-scale testing (Phase 3)Study completedNCT01144364
What this trial is testing

MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 234
Testing effectiveness (Phase 2)UnknownNCT00790244
What this trial is testing

A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall

Who this might be right for
Soft Tissue SarcomaNon Metastatic Disease
Oslo University Hospital 188
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256964
What this trial is testing

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Henan Cancer Hospital 216
Testing effectiveness (Phase 2)Study completedNCT02666898
What this trial is testing

Phase II Trial GA101 Inbrutinib B CLL

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
French Innovative Leukemia Organisation 135
Not applicableUnknownNCT06247293
What this trial is testing

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Who this might be right for
Hyperthermic Intraperitoneal ChemotherapyHepatocellular CarcinomaRuptured Liver
Zhujiang Hospital 100
Next Page